Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $196,609 | -21.7% | 36,075 | -2.4% | 0.00% | – |
Q2 2023 | $251,040 | +1812.5% | 36,972 | +1311.1% | 0.00% | – |
Q1 2023 | $13,126 | +123.8% | 2,620 | +118.0% | 0.00% | – |
Q4 2022 | $5,866 | -100.0% | 1,202 | -99.9% | 0.00% | -100.0% |
Q3 2022 | $19,877,000 | -33.3% | 1,378,466 | -30.1% | 0.00% | -33.3% |
Q2 2022 | $29,819,000 | +27.4% | 1,970,851 | +0.0% | 0.00% | +50.0% |
Q1 2022 | $23,407,000 | -5.4% | 1,970,268 | +29.1% | 0.00% | 0.0% |
Q4 2021 | $24,733,000 | -43.2% | 1,525,787 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $43,546,000 | -16.8% | 1,525,787 | -1.5% | 0.00% | -25.0% |
Q2 2021 | $52,356,000 | +11.8% | 1,548,987 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $46,841,000 | -6.1% | 1,548,987 | +53.8% | 0.00% | 0.0% |
Q4 2020 | $49,865,000 | +16.5% | 1,007,174 | -9.6% | 0.00% | 0.0% |
Q3 2020 | $42,791,000 | -24.4% | 1,114,642 | -15.0% | 0.00% | -33.3% |
Q2 2020 | $56,624,000 | +56.0% | 1,310,742 | -5.8% | 0.01% | +20.0% |
Q1 2020 | $36,301,000 | -16.5% | 1,390,842 | -0.0% | 0.01% | 0.0% |
Q4 2019 | $43,471,000 | +2.6% | 1,391,061 | -14.5% | 0.01% | 0.0% |
Q3 2019 | $42,390,000 | +13.9% | 1,626,642 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $37,201,000 | -12.7% | 1,626,642 | 0.0% | 0.00% | -20.0% |
Q1 2019 | $42,634,000 | +28.9% | 1,626,642 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $33,086,000 | +1.2% | 1,626,642 | +32.2% | 0.01% | +25.0% |
Q3 2018 | $32,686,000 | – | 1,230,642 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
Caligan Partners LP | 23,321 | $127,099 | 0.06% |
Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |